Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges
What should life sciences investors and targets focus on for dealmaking success? Here are six actionable steps.
What should life sciences investors and targets focus on for dealmaking success? Here are six actionable steps.
The defining capability of modern health plans is intelligent engagement with unified infrastructure.
In today’s environment, standing still is the riskiest strategy of all. But to move from plateau to progress, GI practices must redefine what growth looks like.
Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market.